Today

Nemera opens 7,200 m2 drug-delivery device hall in Normandy

Nemera has inaugurated a new 7,200 m2 production hall, Hall 3, at its Ponts-et-Marais site in Seine-Maritime, France, to expand manufacturing capacity for drug-delivery devices. The hall includes a 2,600 m2 cleanroom and will house production of the SP9 pump, allowing the SP2 pump to be centralised at the nearby Le Treport site. Combined, the two sites could add up to 120 million devices in output.

Why this mattersUp to 120 million additional devices across the two Seine-Maritime sites adds European dosing-device capacity for drugmakers and frees Le Treport to specialise on one pump.

  • The 7,200 m2 Hall 3, including a 2,600 m2 cleanroom, was inaugurated on 16 September 2026 after construction began in June 2025.
  • The facility sits on a 46,000 m2 plot and will manufacture the SP9 pump, freeing Le Treport to centralise SP2 pump production.
  • Combined output across Ponts-et-Marais and Le Treport could increase by up to 120 million devices.
  • About 100 employees will join the site over the next two years.
  • The plant targets ISO 14001 and ISO 50001 certification plus a BREEAM Good rating, and runs on electricity only.
  • Nemera employs more than 3,300 people worldwide and reports annual revenue of EUR 700m across 7 production sites on 3 continents.
Nemera
Relevant to you?

Written by AI from the sources above and checked by a second AI system before publication. No human wrote or edited this story. How it is made.